&nbsp;

PCC_4114_FNIMuI_ExecSummary_FR.pdf

Oct 2020

Guidelines and Advice

Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk

Status: Current

Apr 2021

Quality Expectations by Disease Site – Radiation Treatment

Guidelines and Advice

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Status: Current

Apr 2020

Guidelines and Advice

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Status: Current

Oct 2019

Regimen

PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Drugs Used:

pembrolizumab

... Show more tags

Quick Link(s):

Regimen Monograph

Jan 2023

Regimen

CISPFU+PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

CRBPFU+PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

PEMB(MNT)

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Drugs Used:

pembrolizumab

... Show more tags

Quick Link(s):

Regimen Monograph

Jan 2023

Document

obsp-7-10-20.xml

Oct 2020

Document

OBSP-7-10-20.html

Oct 2020

Document